Baioflow Inc.
Baioflow is a DeepTech biotech company focused on AI-driven drug discovery. Their core offering is the Baio-Intelligence Platform, which integrates biological expertise with AI to discover Organ-Crossing Enhancers (OCEs). These OCEs facilitate targeted drug delivery across biological barriers like the blood-brain barrier (BBB). The platform consists of BaioLab™ for generating experimental bio-data, BaioDB™ for structuring this data, BaioAI™ for discovering OCEs, and BaioPartner™ for collaborating with pharmaceutical and biotech companies. Their differentiation lies in generating proprietary experimental data to train their AI models, unlike competitors who rely on theoretical data. Baioflow aims to accelerate the development of CNS and organ-specific therapies by improving the success rate of drug delivery.
Baioflow Inc.
Baioflow is a DeepTech biotech company focused on AI-driven drug discovery. Their core offering is the Baio-Intelligence Platform, which integrates biological expertise with AI to discover Organ-Crossing Enhancers (OCEs). These OCEs facilitate targeted drug delivery across biological barriers like the blood-brain barrier (BBB). The platform consists of BaioLab™ for generating experimental bio-data, BaioDB™ for structuring this data, BaioAI™ for discovering OCEs, and BaioPartner™ for collaborating with pharmaceutical and biotech companies. Their differentiation lies in generating proprietary experimental data to train their AI models, unlike competitors who rely on theoretical data. Baioflow aims to accelerate the development of CNS and organ-specific therapies by improving the success rate of drug delivery.